By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere today said that the US Food and Drug Administration has notified the firm that its Verigene SP respiratory virus panel has been categorized as "moderate complexity" under the Clinical Laboratory Improvement Amendments of 1988.

The test runs on the firm's Verigene SP molecular diagnostics system, the newer version of its flagship Verigene platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.